A long noncoding RNA lincRNA EPS expression level in renal anemia in chronic kidney disease

Basit Öğe Kaydı
dc.contributor.authorGüner, Veysel Berk
dc.contributor.authorTurgut, Faruk
dc.contributor.authorDoğan, Serdar
dc.date.accessioned2025-07-24T11:35:08Z
dc.date.available2025-07-24T11:35:08Z
dc.date.issued2025
dc.departmentTıp Fakültesi
dc.description.abstractChronic Kidney Disease (CKD) is a long-term medical condition characterized by the gradual loss of kidney function over time. Anemia is one of the most important causes of morbidity in patients with CKD. Anemia negatively affects the quality of life and mortality of patients and increases the progression of kidney disease. This is the first study to indicate lincRNA_EPS expression levels in CKD patients with renal anemia. Material and Methods: A total of 59 people were included in this study with 40 patients and 19 control groups. Analyzes of lncRNA expression levels were performed by RT-qPCR method. Total RNA (including miRNA and lncRNA) was obtained from serum and plasma using an RNA isolation kit. Then, RNA concentration and purity were determined spectrophotometrically. The integrity of total RNA was determined by agarose gel electrophoresis. Results: This study concluded that the lincRNA-EPS expression values were found to be significantly higher in the CKD group. There was no statistically significant correlation between the eGFR level of the patients and the lincRNA-EPS expression levels. However, a statistically significant positive correlation was found between eGFR values and hemoglobin levels in the patient group. Discussion: Considering the increased lincRNA-EPS expression level in CKD patients with renal anemia and its inverse correlation with EPO usage, a potential mechanism for facilitating erythropoiesis may involve both elevated lincRNA-EPS expression and suppression of the pro-apoptotic gene Pycard. Larger and more clinical studies are needed to fully elucidate the mechanism of action of the renal anemia-EPOlincRNA-EPS relationship. In the light of these studies, it will be possible to identify new factors that play a role in the formation mechanisms of renal anemia and to evaluate new treatment alternatives.
dc.identifier.doi10.4328/ACAM.22218
dc.identifier.endpage35
dc.identifier.issn2667-663X
dc.identifier.issue1
dc.identifier.startpage30
dc.identifier.urihttps://dx.doi.org/10.4328/ACAM.22218
dc.identifier.urihttps://hdl.handle.net/20.500.12451/13572
dc.identifier.volume16
dc.identifier.wosWOS:001388001300007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.institutionauthorErdal, Hüseyin
dc.language.isoen
dc.publisherBayrakol MP
dc.relation.ispartofAnnals of Clinical and Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectChronic Kidney Disease
dc.subjectRenal Anemia
dc.subjectErythropoietin
dc.subjectLong Non-Coding RNA
dc.subjectlincRNA_EPS
dc.titleA long noncoding RNA lincRNA EPS expression level in renal anemia in chronic kidney disease
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
guner-veysel berk-2025.pdf
Boyut:
301.27 KB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu